[{"from": "human", "value": "Please give me some details about this molecule. [C][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=C][Branch1][#C][N][C][=C][Branch1][=Branch2][C][=C][C][Ring1][=Branch1][=N][Ring1][=Branch2][C][C][C][=Branch1][C][=O][N][Branch1][C][C][C]"}, {"from": "gpt", "value": "The molecule is a hypnotic drug that was initially approved by the FDA in 1992.  Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the duration of sleep, and decreases the number of awakenings during sleep in patients with temporary (transient) insomnia.  It is available in both immediate acting and extended release forms,.   Its tolerability profile is favorable when administered according to the manufacturer\u2019s instructions, with a low risk of drug withdrawal, drug dependence, and drug tolerance. In addition, zolpidem improves sleep quality in patients suffering from chronic insomnia and can show mild muscle relaxant properties. Research also shows that zolpidem is rapid and effective in restoring brain function for patients in a vegetative state following brain injury. This drug has the propensity to completely or partially reverse the abnormal metabolism of damaged brain cells after injury,."}]